Heterotopic glial tissue is a rare, benign congenital anomaly that can present as a fibrous mass with or without overt signs of neural tissue origin, such as overlying alopecia, pigmentation, or a “hair collar” sign. These lesions are typically found in the midline area, though they have been found laterally involving the mastoid and middle ear regions. As demonstrated by this case report, a lateral scalp lesion may represent glial tissue even if fine-needle aspiration does not demonstrate neural findings.
This single case report represents a 7-month-old white infant who presented with a lateral scalp mass over the mastoid area. The mass enlarged as she grew, causing external auditory canal obstruction. Fine-needle aspiration demonstrated fibrovascular tissue, and computed tomographic imaging showed a small bony defect over the mastoid area but no intracranial communication. The final pathologic finding was consistent with glial choristoma, a rare, benign congenital lesion involving heterotopic neural tissue.
Conclusions and Relevance
Congenital scalp lesions can represent heterotopic neural tissue and warrant complete evaluation prior to treatment; fine-needle aspiration biopsy is not necessarily reliable to rule out neurogenic origin, as demonstrated in this case. The possibility for intracranial extension should always be considered and fully evaluated with computed tomography or magnetic resonance imaging prior to operative intervention. Most prior published case reports of heterotopic glial tissue involving the mastoid and/or middle ear spaces describe adults and suggest that such lesions were acquired later in life. This report of a lateral glial choristoma overlying the mastoid bone in an infant supports a congenital origin of this lesion.
Glial choristomas, also known as glial heterotopias, are rare congenital lesions composed of neuroglial tissue connected to the central nervous system. Their origin is speculated to derive from abnormal closure of the neural tube vs sequestration of an acquired encephalocele. These lesions have been documented in the more common perinasal region in the form of nasal glioma but have also been identified in the scalp, oropharynx, nasopharynx, tongue, lip, orbit, chest wall, and lung.1 Scalp lesions are predominantly found in the midline and frequently present with overlying alopecia and a surrounding area of long, coarse hair noted as a “hair collar sign.” Overlying capillary discoloration is also common.2 The middle ear and mastoid regions are especially rare locations for heterotopic glial tissue and have been thought to derive from acquired encephaloceles.3 Nearly all published cases of middle ear and mastoid region heterotopic glial tissue occur in adults. These lesions tend to present later in life in adults with complaints of hearing loss and/or otitis media.4 This case reported herein is unique in that it represents a lateral congenital temporal scalp lesion with extension into the mastoid portion of the temporal bone in an infant.
A 15-day-old white female infant was referred with a left postauricular soft-tissue mass present since birth. The lesion measured approximately 3 cm in the postauricular scalp and was slightly raised and noncompressible. There was no redness, alopecia, overlying capillary staining, or hair collar sign present. There was no bluish hue or other indication of hypervascularity of the lesion. The skin overlying the lesion appeared uninvolved with hair growth consistent with the adjacent normal regions. She had passed her newborn hearing screen and was otherwise developmentally healthy with no anatomic or other abnormal condition (Figure 1).
We elected to follow the mass conservatively, given the patient’s young age. The mass slowly enlarged and began to displace the left auricle anteriorly and inferiorly. A computed tomographic (CT) scan of the temporal bone obtained at 2.5 months of age demonstrated a soft-tissue and fatty mass posterior to the left ear involving the base of the pinna with an area of conical invagination into the outer cortex of the mastoid bone. There was no bony destruction of the left mastoid bone. Some focal soft-tissue penetration was noted in the attic by the radiologist, but her middle and inner ear spaces appeared otherwise unremarkable. No intracranial extension was noted on the CT scan (Figure 2). A needle biopsy was performed under CT guidance, with findings of fibrovascular benign-appearing tissue.
As the child grew, the mass enlarged, causing increasing anterior displacement and deformity of the left pinna. Her mother reported increasing wax impaction, and the left ear canal became increasingly collapsed, resulting in difficulty examining the left tympanic membrane. Because of progressive ear deformity and obstruction, at age 7 months surgical excision was performed with the use of general anesthesia. The lesion was sharply excised. There was no clear capsule, and the overlying skin was fairly thin but otherwise unremarkable. Silverstein facial nerve monitoring was in place in case mastoidectomy was necessary. The lesion was elevated off of the temporal fascia, and centrally a stalk extended into the mastoid cavity, ending in a blind pouch. Periosteum was incised circumferentially around this area, and a sharp elevator was used to remove the residual stalk of tissue. A bony spicule was present in the mastoid extension, which was removed with the specimen. The bone was drilled down 1 to 2 mm with a small diamond burr. There was no visible communication into the intracranial vault or the middle ear space. Postauricular excess skin was trimmed. Left otoplasty with the Mustarde suture technique was performed to reposition the helix and antihelix that had been deformed by pressure from the mass.
In the gross and histopathologic assessment, the specimen consisted of a 3.8 × 2.0 × 1.1-cm, tan, soft-tissue mass and a 3.5 × 1.0-cm ellipse of unremarkable skin. Microscopic examination of the lesion demonstrated mature glial tissue in a background of vascularized fibroadipose tissue. Focal cystically dilated areas contained papillary formations resembling choroid plexus. The glial tissue was composed of a delicate fibrillary network with scattered astrocytes, occasional oligodendrocytes, and microglia. No definitive neurons were seen. Findings from immunohistochemical analysis showed that the glial tissue was positive for glial fibrillary acidic protein. The inner wall of the cystic spaces was lined by cuboidal cells resembling ependymal lining cells (Figure 3).
Postoperatively, she healed well with good position of the left pinna (Figure 4). She was reevaluated at 10 months postoperatively and had good appearance and symmetry of the pinna. There was no evidence of recurrent disease.
Though previous reports of mastoid and middle ear glial choristoma suggest these lesions arise from an acquired encephalocele,3 this case truly represents a congenital glial choristoma of the lateral scalp involving the mastoid portion of the temporal bone in an otherwise healthy infant. Only one other published case of temporal bone region glial choristoma in an infant was found during this search of the English-language literature.5 This supports the theory that lateral heterotopic glial tissue of the middle ear and mastoid bone in infants may result from abnormal closure of the neural tube in utero. This is in contrast to most published cases of glial choristoma in the middle ear and mastoid bone, which present in adults with hearing loss.3,6- 8 It is possible that the cases in adults represent a sequestered encephalocele instead of a congenital anomaly, suggesting there is a bimodal distribution of heterotopic glial tissue in the middle ear and mastoid. Cases presenting in infancy likely represent abnormal neural tube closure, whereas cases in adults may derive from prior encephalocele.
As this case did not demonstrate clinical signs suggestive of a neural tube deformity, such as the hair collar sign or overlying skin discoloration, the importance of preoperative imaging prior to operating on congenital scalp lesions is highlighted and should include lateral lesions as well as midline lesions. In this instance, preoperative biopsy did not suggest glial tissue, and thus needle biopsy cannot be used to definitively rule out heterotopic glial tissue. Congenital scalp masses must always be examined fully for intracranial extension, as in the case of encephalocele or meningocele, with heterotopic glial tissue always remaining in the differential diagnosis. Recommendations include long-term follow-up, although recurrence rates of heterotopic glial tissue have been shown to be very low despite poor encapsulation of the mass.9
Corresponding Author: Mark Armeni, MD, Department of Otolaryngology, West Virginia University, PO Box 9200, Morgantown, WV 26506 (email@example.com).
Author Contributions: Both authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Dunham, Armeni.
Acquisition of data: Dunham, Armeni.
Analysis and interpretation of data: Dunham.
Drafting of the manuscript: Dunham.
Critical revision of the manuscript for important intellectual content: Dunham, Armeni.
Study supervision: Armeni.
Conflict of Interest Disclosures: None reported.
Previous Presentation: This study was presented at the West Virginia University Resident Research Day and received a second-place podium presentation prize in the clinical venue category; May 17, 2012; Morgantown, West Virginia.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Otolaryngology–Head & Neck Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.